| AML |
acute myeloid leukaemia |
| ARE |
antioxidant response element |
| ATM |
Ataxia telangiectasia mutated protein |
| ATR |
Ataxia Telangiectasia and Rad3-related protein |
| ATZ |
aminotriazole |
| Bax |
Bcl-2 associated X protein |
| bcl-2 |
B Cell Lymphoma-2 |
| bcl-xL |
B Cell Lymphoma-extra large |
| B(a)P |
benzo(a)pyrene |
| Bid |
BH3 interacting domain |
| BIRC7 |
Baculoviral IAP Repeat Containing 7 |
| Chk1 |
Checkpoint kinase 1 |
| CHk2 |
Checkpoint Kinase 2 |
| CDK1 |
Cyclin-Dependent Kinase 1 |
| COX |
Cyclooxygenase-2 |
| CXCR4 |
C-X-C Chemokine Receptor type-4 |
| DPPH |
2,2-diphenyl-1-picrylhydrazyl |
| EMT |
Epithelial to Mesenchymal Transition |
| ERK |
Extracellular signal-Regulated Kinase |
| FADD |
Fas Associated Death Domain |
| GSH |
glutathione S-transferase |
| HO-1 |
heme oxygenase |
| H2O2
|
hydrogen peroxide |
| IARC |
International Agency for Research on Cancer |
| ICAM-1 |
Intercellular Adhesion Molecule-1 |
| IκB |
Inhibitor of κB |
| IKK-α |
Inhibitor of NFB Kinase subunit-α |
| IKK-β |
Inhibitor of NFB Kinase subunit-β |
| IL-1R |
Interleukin-1 Receptors |
| IL-6 |
Interleukin-6 |
| IL-8 |
Interleukin-8 |
| IRAK1 |
Interleukin-1 Receptor Activated Kinase 1 |
| IRAK4 |
Interleukin-1 Receptor Activated Kinase 4 |
| KEAP-1 |
Kelch-like ECH-associated protein-1 |
| LDC |
Less Developed Countries |
| LPS |
lipopolysaccharide |
| maf |
musculoaponeurotic fibrosarcoma |
| MAPK |
Mitogen Activated Protein Kinase |
| MDCs |
More developed countries |
| MMP |
matrix metalloproteinase |
| MPP+
|
1-methyl-4-phenylpyridine |
| MTT |
3-(4,5-dimethyl-2-thiozolyl)-2,5-diphenyl-2H-tetrazolium bromide |
| Myd88 |
Myeloid Differentiation Primary Response Gene 88 |
| NEMO |
NFκB Essential Modulator |
| NFκB |
Nuclear Factor -light-chain-enhancer of activated B cells |
| NIK |
NCK Interacting Kinase |
| NQO1 |
NAD(P)H: quinine reductases |
| Nrf2 |
Nuclear factor erythroid 2-Related Factor 2 |
| PDG |
peptidoglycan |
| PK |
pharmacokinetics |
| PMA |
phorbol-12-myristate-13-acetate |
| PPARү |
Peroxisome Proliferator-Activated Receptor ү |
| ROS |
Reactive oxygen species |
| SEAP |
Secreted Embryonic Alkaline Phosphatase |
| SOD |
superoxide |
| TAB1 |
Transforming growth factor beta-activated kinase 1-binding protein 1 |
| TAB2 |
Transforming growth factor beta-activated kinase 1-binding protein 2 |
| TAK1 |
Transforming growth factor beta-activated kinase 1 |
| TLRs |
Toll-like receptors |
| TNF |
Tumour Necrosis Factor |
| TNFR |
Tumour Necrosis Factor Receptor |
| TRADD |
TNFR with Tumour Necrosis Factor Receptor type-1-Associated Death Domain protein |
| TRAF2 |
Tumour Necrosis Factor Receptor-Associated Factor 2 |
| TRAF6 |
Tumour necrosis factor Receptor-Associated Factor 6 |
| VEGF |
Vascular Endothelial Growth Factor |
| XIAP |
X linked Inhibitor of Apoptosis Protein |